Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine
The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow
| Overview / Abstract: |
The clinical multiple myeloma arena has undergone significant advances in diagnosis and prognosis, minimal residual disease monitoring, and supportive care. This expansion brings renewed hope to patients, but it presents new challenges for the clinicians charged with their care. Some patients enjoy many years in clinical remission, whereas for others survival is no more than 2 or 3 years. This reflects the heterogeneity of myeloma and underscores the inappropriateness of a one-size-fits-all management approach. Improving patient outcomes requires building on the foundation of current therapies and ensuring that clinicians are equipped with the knowledge and strategies needed to provide patients with a more personalized approach to treatment. Oncology clinicians have a growing array of tools at their disposal to favorably influence a patient’s quality and quantity of life—but they can only take advantage of these tools by remaining current on the latest research and understanding the appropriate timing and strategies for using newer therapies. |
|
Expiration |
Dec 31, 2019 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Penn State College of Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Paul G. Richardson, MD—Program Co-Chair A. Keith Stewart, MBChB, MRCP, FRCPC, MBA—Program Co-Chair Ajai Chari, MD C. Ola Landgren, MD, PhD María-Victoria Mateos, MD, PhD Gregory J. Orloff, MD |
|
Activity Specialities / Related Topics |
Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
Support for this activity has been provided through educational grants from Adaptive Biotechnologies, Amgen, and Celgene Corporation. |
|
Keywords / Search Terms |
RedMedEd MMRF, MM, multiple myeloma, imaging procedures, cytogenetics, genomics, testing tools, patient prognosis, risk stratification, combination, frontline, risk, patient, characteristics, minimal residual disease, MRD, maintenance therapy, novel agent, monoclonal antibody, relapsed/refractory, RR, genomics, clinical trials, small-molecule inhibitors, inhibitors, immune, oncology, treatment regimens, RedMedEd, PSCM, Free, Free CME Free CE CME |
|